Lymphoma Clinical Trials in New York

Showing 321-340 of 620 trials

Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity

NCT03342586

The purpose of this study is to test resting state functional Magnetic Resonance Imaging (rsfMRI) scans to see if rsfMRI scans are better than the standard task based fMRI scans at diagnosing or monitoring central nervous system lymphoma.

Central Nervous System Lymphoma

Memorial Sloan Kettering Cancer Center14 participantsStarted Nov 2017

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies

NCT01682226

The purpose of this study is to find out whether the addition of blood stem cells from a close family member, when added to umbilical cord blood will make the transplant safer.

LeukemiaMyelodysplastic SyndromeLymphoma

Memorial Sloan Kettering Cancer Center84 participantsStarted Sep 2012

New York, New York, United States

Using a Novel Functional MRI Technique to Evaluate for Neurotoxicity

Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies

Lymphoma Trials in Other Cities

A Study of PLX2853 in Advanced Malignancies.

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

A Study of LY3023414 in Participants With Advanced Cancer

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation

A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)

A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas

Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL)

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients

Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

Study to Evaluate Safety and Preliminary Efficacy of Tafasitamab With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi

Other Conditions in New York